Italian private equity firm Clessidra has launched its fourth buyout fund, Clessidra Capital Partners IV, with a target of €500m and a €600m hard-cap, Unquote understands.
Fund invests in renewable chemistry, regenerative medicine and agri-food across the Netherlands, Belgium and parts of Germany
Company will operate with the GP's existing test and measurement companies in the US and Denmark
Numerous Italian GPs with a generalist approach have reshaped their activity towards the tech sector
GP plans to merge Atlantic with portfolio company Maced, in which it acquired a majority stake last year